CORONEX LIMITED - CLYDEBANK
Company Profile | Company Filings |
Overview
CORONEX LIMITED is a Private Limited Company from CLYDEBANK SCOTLAND and has the status: Dissolved - no longer trading.
CORONEX LIMITED was incorporated 4 years ago on 15/04/2020 and has the registered number: SC659338. The accounts status is MICRO ENTITY.
CORONEX LIMITED was incorporated 4 years ago on 15/04/2020 and has the registered number: SC659338. The accounts status is MICRO ENTITY.
CORONEX LIMITED - CLYDEBANK
This company is listed in the following categories:
72110 - Research and experimental development on biotechnology
72110 - Research and experimental development on biotechnology
Accounts Status
Accounting Year End (d/m) | Accounts Last Made Up Date | Accounts Next Due Date |
---|---|---|
30 / 4 | 30/04/2022 |
Registered Office
GOLDEN JUBLIEE NATIONAL HOSPITAL LEVEL FOUR EAST
CLYDEBANK
G81 4DY
SCOTLAND
This Company Originates in : United Kingdom
Confirmation Statements
Last Statement | Next Statement Due |
---|---|
14/04/2022 | 28/04/2023 |
Map
SCOTLAND
Company Officers - Current and Previous
Name | Born | Nationality | Role | Appointed | Status |
---|---|---|---|---|---|
MR GRAHAM FORGIE WATSON | Jan 1958 | British | Director | 2020-04-15 | CURRENT |
DR GOVINDSINH CHAVADA | Jul 1978 | British | Director | 2020-04-23 | CURRENT |
Persons with Significant Control
Name | Active from | Born | Address | Level of control |
---|---|---|---|---|
Lateral Dx Limited | 2020-04-23 | Dollar Clackmannanshire |
Ownership of shares 25 to 50 percent Voting rights 25 to 50 percent |
|
Scottish Health Innovations Limited | 2020-04-15 - 2020-04-23 | Clydebank |
Ownership of shares 75 to 100 percent Voting rights 75 to 100 percent Right to appoint and remove directors |
Free Reports Available
Report | Date Filed | Date of Report | Assets |
---|---|---|---|
Coronex Limited Filleted accounts for Companies House (small and micro) | 2023-01-25 | 30-04-2022 | £-275 equity |
Coronex Limited Filleted accounts for Companies House (small and micro) | 2022-01-13 | 30-04-2021 | £-28,102 equity |